Author

Allan Augustine

Institutions: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Observed institutions: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

OpenAlex ID: A5017946664

Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant

2020 · Mina D. Aziz, Jay Shah, et al. · Leukemia · 34

Serial Biomarker Monitoring Early after HCT Identifies Different Risks for Relapse and Graft-Vs-Host Disease

2018 · Mina D. Aziz, Jay Shah, et al. · Blood

Works count: 2

Citation count: 34

H-index: 1

I10-index: 1